News
Could boosting fat taste receptors help cut calories?
In mice, fat taste receptor agonists added to food promoted satiation and weight loss.
News
Interval FITs could cut colonoscopies in those at above-average risk
Two or more negative tests could suggest less need for colonoscopy at 5 years, especially in those with a family history of colon cancer.
News
Marriage rates declining for Canadian adolescent mothers?
However, births to mothers younger than 18 years are rare in Canada, and births to married mothers in that age group are even rarer.
News
Double CF combination safe, effective in 1- to 2-year-olds
Ivacaftor/lumacaftor combination could serve as a bridge to triple therapy.
News
Six obstacles in breast cancer detection and treatment
Novel and effective therapies can make a difference only if patients have access to them, oncologists say.
News
Most women with breast cancer elude serious COVID-19 vaccine side effects
The frequency of lymph node swelling was similar to the general population.
News
Breast cancer diagnoses worse among Hispanics during COVID-19 pandemic
A study in San Antonio suggests low insurance coverage rates may be at least partially to blame.
News
Structural racism tied to later-stage breast cancer diagnoses
Black patients were more likely to be diagnosed with triple-negative breast cancer than White patients.
News
Adjuvant chemo tied to better survival in low-risk node-positive breast cancer
The survival advantage was present in all patients under 50 years old.
News
Whole breast radiation for breast cancer shown to be safe and effective
Whole breast radiation can cut treatment time from 6 weeks down to 3 weeks.
News
Immunotherapy may be path forward in HPV oropharyngeal cancer
Immunotherapy benefits locally advanced HPV-positive oropharyngeal cancer in phase 2 study.
News
Latinx and melanoma: Barriers and opportunities
A qualitative study in California reveals challenges and attitudes that could be addressed with new melanoma outreach and prevention strategies....
News
Stage 3 melanoma attacked with immunotherapy and a virus-like particle
Phase 2 trial achieves some success, and responders had infiltrate of plasmacytoid dendritic cells.
News
Exosomes may drive HBV spread
Cellular packaging may also help evade the immune response.
News
Stool transplants may boost immunotherapy success in melanoma
A phase 1 trial shows good clinical response after transplants from healthy donors.